The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration

Florence Berthelot1, Lakhdar Fattoum, Sarah Casulli

  • 1Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMR S 872 et Université Paris Descartes, UMR S 872, INSERM, Paris, France.

Insights

High-mobility group box 1 (HMGB1) regulates polymorphonuclear neutrophil (PMN) migration. HMGB1 can inhibit or attract PMNs depending on concentration, offering potential therapeutic strategies for inflammatory diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Polymorphonuclear neutrophils (PMNs) are crucial for host defense but can exacerbate inflammation.
  • High-mobility group box 1 (HMGB1), an alarmin released during cell death, signals immune responses.
  • Understanding HMGB1's role in PMN behavior is vital for managing inflammatory conditions.

Purpose of the Study:

  • To investigate the dual effect of HMGB1 on human PMN migration.
  • To elucidate the receptor pathways involved in HMGB1-mediated PMN responses.
  • To explore the distinct roles of HMGB1's A and B boxes in PMN recruitment.

Main Methods:

  • Studied human PMN migration in whole-blood samples to preserve native cell states.
  • Utilized varying concentrations of HMGB1 (50-100 ng/ml and 5,000 ng/ml) to assess dose-dependent effects.
  • Investigated the involvement of RAGE, Toll-like receptors 2 and 4, and HMGB1's A and B boxes.

Main Results:

  • Low HMGB1 concentrations (50-100 ng/ml) inhibited PMN migration via RAGE.
  • High HMGB1 concentration (5,000 ng/ml) chemoattracted PMNs by inducing IL-8 production, involving RAGE, TLR2, and TLR4.
  • HMGB1's A box inhibited PMN chemotaxis, while the B box promoted it.

Conclusions:

  • HMGB1 exhibits a concentration-dependent, dual role in regulating PMN recruitment to inflammatory sites.
  • HMGB1's distinct domains (A and B boxes) mediate opposing effects on PMN migration.
  • The HMGB1 A box may offer a therapeutic target to control excessive PMN recruitment in chronic inflammatory disorders.